Nicola Morrice
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Discovery of a CNS active GSK3 degrader using orthogonally reactive linker screening.
Journal: Nature communications
Published: March 09, 2025
Hydroxysteroid 17β-dehydrogenase 13 (Hsd17b13) knockdown attenuates liver steatosis in high-fat diet obese mice.
Journal: Experimental physiology
Published: December 19, 2024
A reciprocal relationship between markers of genomic DNA damage and alpha-synuclein pathology in dementia with Lewy bodies.
Journal: Molecular neurodegeneration
Published: July 17, 2024
Metformin increases the uptake of glucose into the gut from the circulation in high-fat diet-fed male mice, which is enhanced by a reduction in whole-body Slc2a2 expression.
Journal: Molecular metabolism
Published: May 26, 2023
Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR-/- mice.
Journal: Scientific reports
Published: October 19, 2022
Effects of Liraglutide and Fenretinide treatments on the diabetic phenotype of neuronal human BACE1 knock-in mice.
Journal: Biochemical pharmacology
Published: March 25, 2019
Response to comment by Moxon et al.
Journal: Clinical science (London, England : 1979)
Published: November 22, 2017
Pharmacological inhibition of protein tyrosine phosphatase 1B protects against atherosclerotic plaque formation in the LDLR-/- mouse model of atherosclerosis.
Journal: Clinical science (London, England : 1979)
Published: May 24, 2017
Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
Journal: Scientific reports
Published: October 18, 2016
Last Updated: 09/26/2026